Author

Pedro M. Rodrigues

MIR-21-5P DRIVES NASH-ASSOCIATED HEPATOCARCINOGENESIS
MIR-21-5P DRIVES NASH-ASSOCIATED HEPATOCARCINOGENESIS

Pedro M. Rodrigues  et al.

KLF5 UPREGULATION IS A COMMON EVENT IN CHOLANGIOCARCINOMA, ACTING AS AN ONCOGENE AND CONSTITUTING A BAD PROGNOSTIC FACTOR
KLF5 UPREGULATION IS A COMMON EVENT IN CHOLANGIOCARCINOMA, ACTING AS AN ONCOGENE AND CONSTITUTING A BAD PROGNOSTIC FACTOR

Pedro M. Rodrigues  et al.

Rising Star: A role for miRNA-21 in non-alcoholic fatty liver disease (NAFLD) pathogenesis / Genetic risk stratification of NAFLD in clinical care: Where do we stand today?
Rising Star: A role for miRNA-21 in non-alcoholic fatty liver disease (NAFLD) pathogenesis / Genetic risk stratification of NAFLD in clinical care: Where do we stand today?

Pedro M. Rodrigues  et al.

miRNAs as modulators of NAFLD pathogenesis and progression towards liver cancer
miRNAs as modulators of NAFLD pathogenesis and progression towards liver cancer

Pedro M. Rodrigues

NOVEL PLATINUM-BASED CHEMOTHERAPEUTIC AGENTS HALT CHOLANGIOCARCINOMA PROGRESSION THROUGH THE INDUCTION OF DOUBLE-STRAND DNA BREAKS, PREVENTING DNA REPAIR MECHANISMS
NOVEL PLATINUM-BASED CHEMOTHERAPEUTIC AGENTS HALT CHOLANGIOCARCINOMA PROGRESSION THROUGH THE INDUCTION OF DOUBLE-STRAND DNA BREAKS, PREVENTING DNA REPAIR MECHANISMS

Pedro M. Rodrigues  et al.

SCAVENGER RECEPTOR MARCO IS ASSOCIATED WITH AN IMMUNOSUPPRESSIVE MICROENVIRONMENT AND TUMOR PROGRESSION IN INTRAHEPATIC CHOLANGIOCARCINOMA
SCAVENGER RECEPTOR MARCO IS ASSOCIATED WITH AN IMMUNOSUPPRESSIVE MICROENVIRONMENT AND TUMOR PROGRESSION IN INTRAHEPATIC CHOLANGIOCARCINOMA

Pedro M. Rodrigues  et al.

THERAPEUTIC POTENTIAL OF TARGETING PROTEIN HYPER-SUMOYLATION IN CHOLANGIOCARCINOMA
THERAPEUTIC POTENTIAL OF TARGETING PROTEIN HYPER-SUMOYLATION IN CHOLANGIOCARCINOMA

Pedro M. Rodrigues  et al.

Item 1 - 7 / 7
1